AcSDKP: a new potential marker of malignancy of the thyroid gland

The tetrapeptide Acetyl-Ser-Asp-Lys-Pro (AcSDKP) a physiologic inhibitor of stem-cell proliferation is also known for it’s strong angiogenic activity. It has been shown that blood levels of this peptide are increased in some hematological malignancies. However, no data on the concentration of AcSDKP present in solid tumor tissue are available. The aim of… (More)